ACT-ON-DIP: Study Protocol of a Randomized Controlled Trial of a Home-Based ACTion Observation Tele-RehabilitatioN for Upper Limb in Children with DIPlegic Cerebral Palsy
Abstract
Highlights What are the main findings? This is the first study applying AOT specifically to promote upper-limb skills in children and adolescents with diplegic CP. The study adopts a home-based AOT protocol, supported by remote clinical supervision, which increases accessibility for families and allows for a more intensive and flexible delivery of the intervention. The AOT home intervention could be tailored to the different features of children with diplegic CP, allowing video selection from a large, diversified library of actions, making it adaptable to individual needs. What is the implication of the main finding? This study will contribute in building evidence on the efficacy of AOT for diplegic CP, with possible positive effects on daily-life functional tasks and indirect benefits on postural control and balance. Moreover, demonstrating its feasibility could support the wider adoption of AOT in other neurodevelopmental or motor conditions. Through a combination of motor and neuropsychological assessments, the project aims to provide insights into the cognitive components of manual action, such as action planning. The integration of neuroimaging will allow investigation of AOT-induced neuroplasticity and its association with clinical changes. Abstract Background: Children with diplegic Cerebral Palsy often exhibit upper-limb (UL) motor impairments compounded by deficits in visuospatial, sensory, and executive functions. Despite this, research has primarily focused on…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- Patient-Centered Pharmaceutical Design to Improve Acceptability of Medicines: Similarities and Differences in Paediatric and Geriatric Populations
- Evidence-based clinical practice guidelines for irritable bowel syndrome 2020
- Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial
- Gastrointestinal manifestations in COVID-19
- COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist
- Persistent gut barrier damage and commensal bacterial influx following eradication of Giardia infection in mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.